Novel medical antibacterial dressing bag
By adopting layered structure and nanocapsule technology in new medical antibacterial dressing packages, the problem of poor stability of antibacterial peptides and ozone oil is solved, and the independent release of silver ions and chlorhexidine is achieved, which improves the antibacterial effect and wound healing efficiency.
Patent Information
- Application Number
- CN202420238793.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-31
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2034-01-31
AI Technical Summary
The antibacterial peptides and medical ozone oil in existing new medical antibacterial dressing packages have poor stability, which affects the effectiveness during storage and transportation.
Using a combined structure of gauze jacket, adsorption layer, antibacterial layer, layered mesh, chlorhexidine supplement layer, silver ion supplement layer and porous layer, the silver ion and chlorhexidine are separated by layered mesh, and the silver ion is controlled by nanocapsules. Release rate and chemically fix chlorhexidine to improve its stability and durability.
Effectively prevent the chemical reaction between silver ions and chlorhexidine, ensure their independent release, improve antibacterial effect, chlorhexidine quickly kills bacteria, and slowly releases silver ions to maintain the sterile state of wounds, enhancing the wound healing effect.
Smart Images

Figure CN221932370U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of medical and sanitary products, in particular to a new type of medical antibacterial dressing bag. Background Art
[0002] New medical antibacterial dressing packs are medical supplies designed specifically to reduce wound infections. They contain dressings of various sizes and materials, such as hydrophilic hydrogels, alginate or silver ion-treated gauze. These dressings effectively inhibit bacterial growth and promote wound healing by releasing antibacterial agents or utilizing the antibacterial properties of their own materials. Dressing packs are usually packaged sterilely to ensure hygiene and safety, and are equipped with easy-to-peel seals for quick access. In addition, some new dressing packs may also integrate intelligent monitoring technology to track the progress of wound healing and provide real-time data support for medical staff.
[0003] After searching, the patent number "CN213940968U" mentioned in the text that "the utility model relates to the technical field of medical and sanitary products, and discloses a new medical antibacterial dressing package, including a dressing sheet. The dressing sheet is provided with a polyurethane film layer, a polyurethane viscose non-woven fabric layer, a hydrogel layer and a soft silicone layer from the outside to the inside. The hydrogel layer contains medical ozone oil and antimicrobial peptides, and the soft silicone layer is provided with micropores. The utility model has no other toxic side effects, fits the wound, provides a good sterile environment for wound healing, can promote accelerated wound healing and reduce scar formation, and reduce the occurrence of complications; its usage is no different from ordinary dressings commonly used in clinical practice, and is easy to package and use, easy to use and easy to carry." When in use, ozone oil and antimicrobial peptides are arranged in the hydrogel layer to disinfect the wound. However, antimicrobial peptides and medical ozone oil have poor stability and have high requirements for the storage environment. They may lose their effectiveness during storage and transportation.
[0004] Therefore, we provide a new type of medical antibacterial dressing package to solve the above problems. Utility Model Content
[0005] The purpose of the utility model is to provide a new type of medical antibacterial dressing bag to solve the problems raised in the above background technology.
[0006] To achieve the above-mentioned purpose, the utility model provides the following technical solutions: a new medical antibacterial dressing bag, comprising a gauze outer jacket, an adsorption layer and an antibacterial layer, the inner side of the gauze outer jacket is provided with an adsorption layer, the top of the adsorption layer is adhered with an antibacterial layer, and a layered net is provided above the antibacterial layer.
[0007] Preferably, an adsorption layer is provided on the inner side of the gauze outer jacket, and the adsorption layer is made of fibrous alginate through a non-woven fabric production process.
[0008] Preferably, an antibacterial layer is adhered to the top of the adsorption layer, and the antibacterial layer is made of synthetic fiber.
[0009] Preferably, a chlorhexidine supplementary layer is provided between the antibacterial layer and the layered net, and the chlorhexidine supplementary layer combines the chlorhexidine with the molecular chains in the supplementary layer by a chemical method, so that the chlorhexidine is fixed on the supplementary layer.
[0010] Preferably, a silver ion replenishing layer is provided on the top of the layered net, and nanocapsules encapsulating silver ion agents are provided in the silver ion replenishing layer.
[0011] Preferably, the layered network is located between the chlorhexidine supplement layer and the silver ion supplement layer, and the layered network is made of a polymer film.
[0012] Preferably, a porous layer is disposed below the adsorption layer, and the porous layer is made of a polyurethane film.
[0013] Compared with the prior art, the beneficial effects of the utility model are:
[0014] 1. Through the setting of the layered net, silver ions and chlorhexidine can be separated to prevent chemical reactions that may occur between the two and affect their antibacterial effects. The layered net can release silver ions and chlorhexidine to the wound one after another to avoid mutual interference and improve the treatment effect.
[0015] 2. Through the setting of the chlorhexidine supplement layer and the silver ion supplement layer, when used, chlorhexidine has a broad-spectrum antibacterial effect and a strong bactericidal effect, and is released quickly, which can quickly kill bacteria in the wound. Silver ions have a broad-spectrum antibacterial effect and can be slowly released from the dressing, maintaining the antibacterial effect for a long time, maintaining the sterile state of the wound, and facilitating the healing of the wound. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 This is a schematic diagram of the overall appearance structure of the utility model;
[0017] Figure 2 It is a schematic diagram of the overall internal structure of the utility model;
[0018] Figure 3 It is a schematic diagram of the overall cross-sectional structure of the utility model;
[0019] Figure 4 It is a schematic diagram of the overall explosion structure of the utility model.
[0020] Numbers in the figure: 1, gauze cover; 2, adsorption layer; 3, antibacterial layer; 4, layered net; 5, chlorhexidine supplement layer; 6, silver ion supplement layer; 7, porous layer. DETAILED DESCRIPTION
[0021] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.
[0022] Embodiment 1
[0023] See also Figure 1-4 As shown, the utility model provides a technical solution: a new medical antibacterial dressing package, comprising a gauze jacket 1, an adsorption layer 2 and an antibacterial layer 3, the adsorption layer 2 is arranged on the inner side of the gauze jacket 1, the antibacterial layer 3 is adhered to the top of the adsorption layer 2, and a layered net 4 is arranged above the antibacterial layer 3.
[0024] Furthermore, an adsorption layer 2 is provided on the inner side of the gauze jacket 1. The adsorption layer 2 is made of fibrous alginate through a non-woven fabric production process. Alginate is a natural polysaccharide with good biocompatibility and absorbency. It can absorb wound exudate to form a gel-like substance to keep the wound dry.
[0025] Furthermore, an antibacterial layer 3 is pasted on the top of the adsorption layer 2. The antibacterial layer 3 is made of synthetic fibers and is used to contain antibacterial materials when in use. It can sterilize the wound to a certain extent, effectively inhibit the growth of bacteria, fungi and other microorganisms, and reduce the risk of infection.
[0026] Furthermore, a chlorhexidine supplementary layer 5 is provided between the antibacterial layer 3 and the layered net 4. The chlorhexidine supplementary layer 5 combines the chlorhexidine with the molecular chains in the supplementary layer by a chemical method, so that the chlorhexidine is fixed on the supplementary layer. The chlorhexidine supplementary layer 5 sets the chlorhexidine in the chlorhexidine supplementary layer 5 by chemical bonding, thereby improving the stability and durability of the chlorhexidine and realizing rapid release.
[0027] Furthermore, a silver ion replenishing layer 6 is arranged on the top of the layered net 4, and nanocapsules encapsulating silver ion agents are arranged in the silver ion replenishing layer 6. By setting the silver ions in the silver ion replenishing layer 6 through the nanocapsules, the release rate of the silver ions can be controlled to achieve a long-term antibacterial effect.
[0028] Furthermore, the layered net 4 is located between the chlorhexidine supplement layer 5 and the silver ion supplement layer 6. The layered net 4 is made of a polymer film and is used to separate the chlorhexidine supplement layer 5 and the silver ion supplement layer 6 to prevent the chlorhexidine and silver ions from mixing and chemically reacting during transportation and storage, thereby affecting their antibacterial effects. At the same time, the layered net 4 can allow the silver ions and chlorhexidine to be released to the wound independently to avoid mutual interference and improve the treatment effect.
[0029] Furthermore, a porous layer 7 is provided under the adsorption layer 2, and the porous layer 7 is made of a polyurethane film. The provision of the porous layer 7 helps to ensure air circulation, maintain the dryness and breathability of the wound, and is also beneficial for the release of chlorhexidine and silver ions to the wound for sterilization.
[0030] Working principle: First, a new type of medical antibacterial dressing pack is moved to the working position. When in use, in the first step, medical staff use samples such as iodine and alcohol to clean and disinfect the patient's wound. After the treatment is completed, the dressing pack is placed on the wound, and then the dressing pack is fixed to the patient with gauze or a bandage. In the second step, the adsorption layer 2 absorbs blood, pus and other secretions that may be produced on the surface of the wound during the wound healing process to keep the wound dry and clean. In the third step, the chlorhexidine in the chlorhexidine supplement layer 5 is released into the antibacterial layer 3 to effectively disinfect the wound and quickly kill a variety of bacteria. In the fourth step, after the chlorhexidine is released, the silver ion supplement layer 6 releases silver ions into the antibacterial layer 3 to permanently disinfect the wound. This completes the use process of a new type of medical antibacterial dressing pack.
[0031] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A novel medical antibacterial dressing pack, comprising a gauze outer cover (1), an adsorption layer (2) and an antibacterial layer (3), characterized in that: An adsorption layer (2) is arranged on the inner side of the gauze jacket (1), an antibacterial layer (3) is adhered to the top of the adsorption layer (2), and a layered net (4) is arranged above the antibacterial layer (3).
2. A novel medical antibacterial dressing pack according to claim 1, characterized in that: An adsorption layer (2) is arranged on the inner side of the gauze outer cover (1), and the adsorption layer (2) is made of fibrous alginate through a non-woven fabric production process.
3. A novel medical antibacterial dressing pack according to claim 1, characterized in that: An antibacterial layer (3) is adhered to the top of the adsorption layer (2), and the antibacterial layer (3) is made of synthetic fibers.
4. A novel medical antibacterial dressing pack according to claim 1, characterized in that: A chlorhexidine supplementary layer (5) is provided between the antibacterial layer (3) and the layered net (4), and the chlorhexidine supplementary layer (5) combines the chlorhexidine with the molecular chains in the supplementary layer by a chemical method, so that the chlorhexidine is fixed on the supplementary layer.
5. A novel medical antibacterial dressing pack according to claim 1, characterized in that: A silver ion replenishing layer (6) is arranged on the top of the layered net (4), and nanocapsules encapsulating silver ion agents are arranged in the silver ion replenishing layer (6).
6. A novel medical antibacterial dressing pack according to claim 1, characterized in that: The layered network (4) is located between the chlorhexidine supplement layer (5) and the silver ion supplement layer (6), and the layered network (4) is made of a polymer film.
7. The novel medical antibacterial dressing package according to claim 1, characterized in that: A porous layer (7) is arranged below the adsorption layer (2), and the porous layer (7) is made of a polyurethane film.
